Professional medical & aesthetic supply For eligible business and healthcare customers
Contact Sales ↗
Home/Our Products/Sandostatin LAR 20 mg
Sandostatin LAR 20 mg

Sandostatin LAR 20 mg

Capacity: 20 mg · kit
Category: Specialty Care, Oncology
Availability: In stock
More product details ›
Quantity:
Request a Quote

Sandostatin LAR 20 mg (Octreotide) by Novartis.

Indications: Acromegaly; symptoms of functional gastro-entero-pancreatic neuroendocrine tumours (carcinoid, VIPomas); advanced midgut NETs.

Administration: Deep intragluteal injection every 4 weeks by a healthcare professional.

Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.

Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.

ManufacturerNovartis
Active ingredientOctreotide (as acetate) 20 mg — long-acting somatostatin analogue.
Strength & pack1 vial powder + pre-filled syringe of solvent, with vial adapter and needle.
FormPowder and solvent for suspension for injection
StorageStore in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Regulatory statusPrescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.